228 related articles for article (PubMed ID: 11258505)
1. TB prevention in HIV clinics in New York City.
Sackoff JE; Torian LV; Frieden TR
Int J Tuberc Lung Dis; 2001 Feb; 5(2):123-8. PubMed ID: 11258505
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.
Mohammed A; Myer L; Ehrlich R; Wood R; Cilliers F; Maartens G
Int J Tuberc Lung Dis; 2007 Oct; 11(10):1114-20. PubMed ID: 17945069
[TBL] [Abstract][Full Text] [Related]
3. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H;
Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
Sterling TR; Brehm WT; Moore RD; Chaisson RE
Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
[TBL] [Abstract][Full Text] [Related]
5. [HIV infection, tuberculosis and tuberculin test in Switzerland. The Swiss HIV Cohort Study].
Sudre P; Rieder H; Bassetti S; Hirschel BJ; Ledergerber B; Malvy D
Schweiz Med Wochenschr; 1996 Nov; 126(47):2007-12. PubMed ID: 8984608
[TBL] [Abstract][Full Text] [Related]
6. INH preventive therapy among adult HIV-infected patients in Thailand.
Hiransuthikul N; Nelson KE; Hiransuthikul P; Vorayingyong A; Paewplot R
Int J Tuberc Lung Dis; 2005 Mar; 9(3):270-5. PubMed ID: 15786889
[TBL] [Abstract][Full Text] [Related]
7. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
[TBL] [Abstract][Full Text] [Related]
8. Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients.
Khawcharoenporn T; Apisarnthanarak A; Manosuthi W; Sungkanuparph S; Mundy LM
Int J Tuberc Lung Dis; 2012; 16(3):336-41. PubMed ID: 22230143
[TBL] [Abstract][Full Text] [Related]
9. Low adherence to guidelines for preventing TB among persons with newly diagnosed HIV infection, United States.
Lee LM; Lobato MN; Buskin SE; Morse A; Costa OS
Int J Tuberc Lung Dis; 2006 Feb; 10(2):209-14. PubMed ID: 16499263
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.
Vikrant S; Agarwal SK; Gupta S; Bhowmik D; Tiwari SC; Dash SC; Guleria S; Mehta SN
Transpl Infect Dis; 2005; 7(3-4):99-108. PubMed ID: 16390397
[TBL] [Abstract][Full Text] [Related]
11. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.
Gupta A; Nayak U; Ram M; Bhosale R; Patil S; Basavraj A; Kakrani A; Philip S; Desai D; Sastry J; Bollinger RC;
Clin Infect Dis; 2007 Jul; 45(2):241-9. PubMed ID: 17578786
[TBL] [Abstract][Full Text] [Related]
12. Primary and secondary tuberculosis preventive treatment in HIV clinics: simulating alternative strategies.
Basu S; Maru D; Poolman E; Galvani A
Int J Tuberc Lung Dis; 2009 May; 13(5):652-8. PubMed ID: 19383201
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
Scholten JN; Driver CR; Munsiff SS; Kaye K; Rubino MA; Gourevitch MN; Trim C; Amofa J; Seewald R; Highley E; Fujiwara PI
Clin Infect Dis; 2003 Dec; 37(12):1686-92. PubMed ID: 14689352
[TBL] [Abstract][Full Text] [Related]
14. [Results and significance of a baseline tuberculin skin test programme among health care workers in a hospital setting].
Gerbaudo L; Violante B
Med Lav; 2007; 98(3):221-31. PubMed ID: 17598350
[TBL] [Abstract][Full Text] [Related]
15. Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS.
Gutierrez EB; Gomes V; Picone CM; Suga H; Atomiya AN
HIV Med; 2009 Oct; 10(9):564-72. PubMed ID: 19785665
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis prevention for non-US-born pregnant women.
Sackoff JE; Pfeiffer MR; Driver CR; Streett LS; Munsiff SS; DeHovitz JA
Am J Obstet Gynecol; 2006 Feb; 194(2):451-6. PubMed ID: 16458645
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok.
Hiransuthikul N; Hanvanich M; Dore GJ; Mokkhawes T; Li Y; Perriens J; Kaldor JM
Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):804-9. PubMed ID: 15115092
[TBL] [Abstract][Full Text] [Related]
18. Reduction of clinical tuberculosis in HIV-infected males with isoniazid prophylaxis.
Alaei K; Alaei A; Mansouri D
East Mediterr Health J; 2002 Nov; 8(6):754-7. PubMed ID: 15568452
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis and HIV infection: a cohort study of incidence and susceptibility to antituberculous drugs, Bordeaux, 1985-1993. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
Dupon M; Texier-Maugein J; Leroy V; Sentilhes A; Pellegrin JL; Morlat P; Ragnaud JM; ChĂȘne G; Dabis F
AIDS; 1995 Jun; 9(6):577-83. PubMed ID: 7662196
[TBL] [Abstract][Full Text] [Related]
20. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]